© 2004 by the American Diabetes Association, Inc.
Standards of Medical Care in DiabetesAmerican Diabetes Association
Abbreviations: ABI, ankle-brachial index ARB, angiotensin receptor blocker CAD, coronary artery disease CHD, coronary heart disease CSII, continuous subcutaneous insulin injection CVD, cardiovascular disease FPG, fasting plasma glucose GCT, glucose challenge test DCCB, dihydropyridine calcium channel blocker DCCT, Diabetes Control and Complications Trial DKA, diabetic ketoacidosis DRS, Diabetic Retinopathy Study ECG, electrocardiogram eGFR, estimated GFR ESRD, end-stage renal disease ETDRS, Early Treatment Diabetic Retinopathy Study GDM, gestational diabetes mellitus GFR, glomerular filtration rate HRC, high-risk characteristic IFG, impaired fasting glucose IGT, impaired glucose tolerance MNT, medical nutrition therapy NPDR, nonproliferative diabetic retinopathy OGTT, oral glucose tolerance test PAD, peripheral arterial disease PDR, proliferative diabetic retinopathy PPG, postprandidial plasma glucose SMBG, self-monitoring of blood glucose UKPDS, U.K. Prospective Diabetes Study
Diabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes. These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested persons with the components of diabetes care, treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude more extensive evaluation and management of the patient by other specialists as needed. For more detailed information, refer to Bode (Ed.): Medical Management of Type 1 Diabetes (1), Zimmerman (Ed.): Medical Management of Type 2 Diabetes (2), and Klingensmith (Ed): Intensive Diabetes Management (3). The recommendations included are diagnostic and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system (Table 1), developed by the American Diabetes Association (ADA) and modeled after existing methods, was utilized to clarify and codify the evidence that forms the basis for the recommendations. The level of evidence that supports each recommendation is listed after each recommendation using the letters A, B, C, or E.
Classification In 1997, the ADA issued new diagnostic and classification criteria (4); in 2003, modifications were made regarding the diagnosis of impaired fasting glucose (IFG) (5). The classification of diabetes includes four clinical classes:
Screening Detection and diagnosis of GDM Recommendations
Glycemic control Referral for diabetes management Intercurrent illness Recommendations
SMBG Recommendations A1C Recommendations
Recommendations
Recommendations
I. CVD: management of risk factors and screening for coronary artery disease A. Blood pressure control Recommendations B. Lipid management Recommendations C. Anti-platelet agents in diabetes Recommendation D. Smoking cessation Recommendations E. CHD screening and treatment Recommendations II. Nephropathy screening and treatment Recommendations General recommendations Screening Treatment III. Diabetic retinopathy screening and treatment Recommendations General recommendations Screening Treatment IV. Foot care Recommendations
I. Preconception care Recommendations II. Immunization Recommendations
I. Care of older adults with diabetes II. Children and adolescents Strategies for improving diabetes care This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||